Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring because their cancer is more likely to recur. Read more
Medical News - Dec 18
A new combination therapy for hormone-resistant ER+ breast cancer shrank tumors and reprogrammed the immunosuppressive tumor microenvironment in both in mouse models and in patient-derived explants. The post Macrophage-Blocking Antibodies Help Overcome Breast Cancer Endocrine Resistance appeared ... Read more
Gen - Nov 05
A multicenter Phase II clinical trial led by researchers at The University of Texas MD Anderson Cancer Center demonstrated significant tumor shrinkage and disease control in patients with advanced pheochromocytoma and paraganglioma (PPGL), two rare and potentially life-threatening neuroendocrine ... Read more
Medical News - Oct 19
